These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36041020)

  • 21. Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores.
    Spindle TR; Sholler DJ; Cone EJ; Murphy TP; ElSohly M; Winecker RE; Flegel RR; Bonn-Miller MO; Vandrey R
    JAMA Netw Open; 2022 Jul; 5(7):e2223019. PubMed ID: 35857320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabinoid-induced autophagy: Protective or death role?
    Costa L; Amaral C; Teixeira N; Correia-da-Silva G; Fonseca BM
    Prostaglandins Other Lipid Mediat; 2016 Jan; 122():54-63. PubMed ID: 26732541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delta-8, Delta-10, HHC, THC-O, THCP, and THCV: What Should We Call These Products?
    Rossheim ME; LoParco CR; Henry D; Trangenstein PJ; Walters ST
    J Stud Alcohol Drugs; 2023 May; 84(3):357-360. PubMed ID: 36971760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cannabis and cannabinoids as drugs].
    Khiabani HZ; Mørland J
    Tidsskr Nor Laegeforen; 2007 Mar; 127(5):579-82. PubMed ID: 17332810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a validated method for rapid quantification of up to sixteen cannabinoids using ultra-high-performance liquid chromatography diode-array detector with optional electrospray ionization time-of-flight mass spectrometry detection.
    Song L; Carlson S; Valenzuela G; Chao M; Pathipaka SB
    J Chromatogr A; 2022 May; 1670():462953. PubMed ID: 35334372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phytocannabinoids beyond the Cannabis plant - do they exist?
    Gertsch J; Pertwee RG; Di Marzo V
    Br J Pharmacol; 2010 Jun; 160(3):523-9. PubMed ID: 20590562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology of Medical Cannabis.
    Amin MR; Ali DW
    Adv Exp Med Biol; 2019; 1162():151-165. PubMed ID: 31332738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Δ
    Babalonis S; Raup-Konsavage WM; Akpunonu PD; Balla A; Vrana KE
    Cannabis Cannabinoid Res; 2021 Oct; 6(5):362-365. PubMed ID: 34662224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?
    Khalid S; Almalki FA; Hadda TB; Bader A; Abu-Izneid T; Berredjem M; Elsharkawy ER; Alqahtani AM
    Curr Pharm Des; 2021; 27(13):1564-1578. PubMed ID: 33267756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
    Rice J; Cameron M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB
    Wang XF; Galaj E; Bi GH; Zhang C; He Y; Zhan J; Bauman MH; Gardner EL; Xi ZX
    Br J Pharmacol; 2020 Apr; 177(8):1865-1880. PubMed ID: 31877572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabis: discrimination of "internal bliss"?
    Wiley JL
    Pharmacol Biochem Behav; 1999 Oct; 64(2):257-60. PubMed ID: 10515300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabis-based medicines and pain: a review of potential synergistic and entourage effects.
    Anand U; Pacchetti B; Anand P; Sodergren MH
    Pain Manag; 2021 Apr; 11(4):395-403. PubMed ID: 33703917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot.
    Pennypacker SD; Cunnane K; Cash MC; Romero-Sandoval EA
    Front Pharmacol; 2022; 13():921493. PubMed ID: 35734402
    [No Abstract]   [Full Text] [Related]  

  • 35. Phytocannabinoids as novel therapeutic agents in CNS disorders.
    Hill AJ; Williams CM; Whalley BJ; Stephens GJ
    Pharmacol Ther; 2012 Jan; 133(1):79-97. PubMed ID: 21924288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Examining impairment and kinetic patterns associated with recent use of hemp-derived Δ
    Wurz GT; Montoya E; DeGregorio MW
    J Cannabis Res; 2022 Jul; 4(1):36. PubMed ID: 35799289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects.
    Roser P; Gallinat J; Weinberg G; Juckel G; Gorynia I; Stadelmann AM
    Eur Arch Psychiatry Clin Neurosci; 2009 Aug; 259(5):284-92. PubMed ID: 19224107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.
    Wiley JL; Marusich JA; Lefever TW; Grabenauer M; Moore KN; Thomas BF
    Neuropharmacology; 2013 Dec; 75():145-54. PubMed ID: 23916483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychoactive constituents of cannabis and their clinical implications: a systematic review.
    Casajuana Köguel C; López-Pelayo H; Balcells-Olivero MM; Colom J; Gual A
    Adicciones; 2018 Apr; 30(2):140-151. PubMed ID: 28492950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology and toxicology of Cannabis derivatives and endocannabinoid agonists.
    Gerra G; Zaimovic A; Gerra ML; Ciccocioppo R; Cippitelli A; Serpelloni G; Somaini L
    Recent Pat CNS Drug Discov; 2010 Jan; 5(1):46-52. PubMed ID: 19832688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.